Patient Buzz Series: Sephora Kids
208332083320833
Tweens and teens are now crazed about skin care products, posting videos on social media about their multi-step skincare routines and love of Sephora. According to Good Morning America, #tweenskincare has more than 49 million views on TikTok.
Dermatologists warn that the products chosen aren’t just expensive, but they may be harmful to a child’s skin. In a Good Morning America segment, Dr. …
Tweens and teens are now crazed about skin care products, posting videos on social media about their multi-step skincare routines and love of Sephora. According to Good Morning America, #tweenskincare has more than 49 million views on TikTok.
Dermatologists warn that the products chosen aren’t just expensive, but they may be harmful to a child’s skin. In a Good Morning America segment, Dr. … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed dermatologist Dr. Victoria Barbosa, associate professor at University of Chicago Medicine. Watch as Dr. Barbosa shares why it may be challenging for an alopecia patient to visit a dermatologist and why it’s important to address the psychological burden of hair loss. Hear how considering a broad differential is essential t … 
Stylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work?
For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St … 
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma … 
Media attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times.
To find out more about oral minoxidil access, … 